Autonomix (AMIX) Enterprise Value to EBITDA Ratio
Autonomix Medical, Inc. (AMIX) faces a liquidity shortage and uncertainty regarding the outcomes of tests for its new neurosensory systems. Meanwhile, ownership of an exclusive nerve impulse control method allows the firm to maintain pricing power by charging a premium for the minimization of medical errors. The current EV/EBITDA ratio stands at 0.00. This price chart reflects the dynamics of an asset whose risks are mitigated by the expansion of its toolset for combating oncological pain.
Comprehensive metric breakdowns and analytics for autonomix.com (AMIX)
- current price and projected stock value:
- market capitalization details:
- business book valuation details:
- debt burden and liquidity indicators:
Total Debt to Equity Ratio Autonomix Medical, Inc.|AMIX - Long-Term Debt to Capital Coefficient|Short-Term Debt to Equity Autonomix Medical|AMIX - Company Total Debt|Debts to Book Capitalization Autonomix Medical, Inc.|AMIX - Long-Term Debt|Company Short-Term Debts Autonomix Medical|Quick Ratio autonomix.com
- financial results and valuation multiples details:
AMIX - Net Financial Result|Projected Future Earnings Autonomix Medical, Inc.|AMIX - Price to Earnings Ratio|Forward P/E Multiple Autonomix Medical|AMIX - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Autonomix Medical, Inc.|AMIX - Profit before payment of interest, taxes and amortization|Net earnings per share for the last 12 months Autonomix Medical|AMIX - Earnings per share for the trailing year|Quarterly EPS earnings growth autonomix.com|AMIX - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Autonomix Medical, Inc.
Analysis of all company metrics:Autonomix AMIX
For Autonomix Medical, Inc. (AMIX), which lacks stable revenues, this indicator serves as a measure of the gap between market expectations and operational reality. The EV/EBITDA trend compares the company's total enterprise value, including debt, with its earnings before interest, taxes, depreciation, and amortization. In the absence of commercial products, an upward trend on the chart signals speculative overheating of valuation amid inertial capital consumption.
Competitor analysis
EV/EBITDA Multiple BSX (Boston Scientific Inc)|Total Company Value to Operating Income Before Depreciation Ratio Edwards Lifesciences Inc. (EW)|RMD: Enterprise Value to EBITDA Ratio|Company Value to Operating Income Before Depreciation Ratio PODD|ZBH: EV/EBITDA Multiple|Company Value to EBITDA The Cooper Companies, Inc. (COO)|ALGN (Align Technology Inc) - EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation GMED (NuVasive)|Enterprise Value to EBITDA Ratio TMDX (TransMedics)|ATEC (atecspine.com) - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Artivion AORT|ENOV - Enterprise Value to EBITDA Ratio|Integra - EV/EBITDA Multiple|Company Value to EBITDA Establishment Labs Inc|BBNX: EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation IRMD|EMBC (Embecta) - EV/EBITDA Multiple|Tandem Diabetes Care Inc (TNDM) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple AXGN|Enterprise Value to EBITDA Ratio SI-BONE Medical SIBN|EV/EBITDA Multiple OFIX (Orthofix Medical Inc.)|EV/EBITDA Multiple bioventus.com BVS|KIDS - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|TMCI: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|SRTA (Strata Critical Medical Corp) - Enterprise Value to EBITDA Ratio|Carlsmed Medical - Business Value to Operating Income Before Depreciation|RXST (RxSight, Inc.) - EV/EBITDA Multiple|Company Value to EBITDA ClearPoint CLPT|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Stereotaxis (STXS)|Neuronetics Inc. (STIM) - Enterprise Value to EBITDA Multiple|Sight Sciences, Inc - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple orchestrabiomed.com OBIO|Anika - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio inspiremd.com NSPR|zhjmedical.com (ZJYL) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio VANI (Vivani Medical)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Xtant Medical Holdings, Inc.|Enterprise Value to EBITDA Ratio NeuroOne Medical Technologies Corp. (NMTC)|EV/EBITDA Multiple MODD|MYO - Company Value to EBITDA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Envoy Medical COCH|VVOS: Enterprise Value to Operating Income Before Depreciation|NVNO: Enterprise Value to EBITDA Ratio|Sintx Technologies - Enterprise Value to Operating Income Before Depreciation Ratio|TNON: EV/EBITDA Multiple|rewalk.com (LFWD) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio IVF|EV/EBITDA Multiple Bone Biologics Corp.|Enterprise Value to EBITDA Ratio AXNX (Axonics Modulation Technologies)|Enterprise Value to Operating Income Before Depreciation Ratio BIOL|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Dynatronics DYNT|Paragon 28 Inc. (FNA) - Company Value to EBITDA|INVO - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization
